Pro Dex Stock Pattern Recognition Engulfing Pattern

PDEX Stock  USD 49.32  0.86  1.77%   
Use the pattern recognition workspace to apply Engulfing Pattern recognition and other studies to Pro Dex. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.

Recognition
This analysis covers fifty-nine data points across the selected time horizon. The function generated a total of seven valid pattern recognition events for the selected time horizon. The Engulfing Pattern describes Pro Dex bullish reversal pattern.

Pro Dex Technical Analysis Modules

Most technical analysis of Pro Dex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pro from various momentum indicators to cycle indicators. When you analyze Pro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company was founded in 1978 and is headquartered in Irvine, California. Pro Dex operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. The profile for Pro Dex integrates fundamentals, price behavior, and sector exposure. The asset's responsiveness to economic cycles appears relatively balanced. Pro Dex has a market cap of 158.08 M, P/E of 13.3, ROE of 30.87%.

Methodology

Unless otherwise specified, financial data for Pro Dex is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Pro (USA Stocks:PDEX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Pro Dex has active sell-side coverage. Source-validated coverage currently shows 1 approved analyst, while broader market-consensus totals may differ across providers due to methodology and update timing. Representative analyst firms may include HSBC Global Research, Wells Fargo Securities, Goldman Sachs, Guggenheim Securities, RBC Capital Markets, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 20th, 2026

Become your own money manager

Portfolio analytics tied to Pro Dex help investors review performance in context instead of judging the holding in isolation. Used properly, the workflow gives investors clearer signals on when to hold, resize, hedge, or replace the position.

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Social Domain Idea
Social Domain
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Momentum Idea
Momentum
Invested over 40 shares
Video Games Idea
Video Games
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 20 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Data Storage Idea
Data Storage
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 20 shares
Investor Favorites Idea
Investor Favorites
Invested few shares

More Resources for Pro Stock Analysis

Understanding Pro Dex typically begins with financial statements and long-term trend review. Pro Dex's financial ratios translate raw accounting data into comparable profitability and efficiency signals. Selected reports below provide context for Pro Stock:
Pro Dex has a market cap of 158.08 M, operating margin of 17.46%, ROE of 30.87%. Use Your Equity Center to explore allocation context. This includes a position in Pro Dex within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Pro Stock, please use our How to Invest in Pro Dex guide.
At P/E 13.3 and ROE 30.87%, Pro Dex analysis should be read alongside other portfolio and risk tools before adjusting capital allocation. That valuation within Healthcare invites comparison with Medical Instruments & Supplies peers using the tools below to judge whether the multiple is justified. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
 Quarterly Earnings Growth
0.082
 Earnings Share
3.41
 Revenue Per Share
22.127
 Quarterly Revenue Growth
0.111
 Return On Assets
0.1157
Investors evaluate Pro Dex using market value and book value, each describing different facets of the business. Pro Dex's market capitalization is 158.08 M. The 3.68 P/B ratio shows Pro Dex carries a substantial premium over its balance-sheet equity. Enterprise value stands at 155.32 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for Pro Dex are related but not identical, and they can diverge across cycles. For Pro Dex, key inputs include a P/E ratio of 13.3, a P/B ratio of 3.68, a profit margin of 15.73%, and ROE of 30.87%. In practice, Pro Dex price is set by the continuous auction process on its listing exchange.